{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:40:45Z","timestamp":1648503645959},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:p>Neurocysticercosis is a parasitic disease that affects the central nervous system. The objective of this study was to investigate the correlation between neuronal death evaluated by the quantification of Fas apoptotic factor and the different evolutive forms of neurocysticercosis accompanied or not by epileptic seizures. METHODS: Cerebrospinal fluid samples from 36 patients with a diagnosis of neurocysticercosis divided into the following groups: active cystic form (n=15), 9 patients with and 6 without seizures, and calcified form (=21), 9 with and 12 without seizures. Fourteen patients comprised the control group. Fas protein concentrations were determined by ELISA. RESULTS: Only the group of patients with calcified cysts without seizures presented cerebrospinal fluid levels of Fas similar to those of the control group. Higher levels were observed for the other groups. CONCLUSIONS: The present finding suggests high cerebrospinal fluid levels of soluble Fas protein, except for patients with calcified cysts without seizures. Significant differences were observed for the group with calcified cysts and seizures, suggesting greater neuronal damage in these patients. Replacement of the term inactive cyst with reactive inactive cyst is suggested.<\/jats:p>","DOI":"10.1590\/s0004-282x2012000400007","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T14:31:02Z","timestamp":1490970662000},"page":"262-266","source":"Crossref","is-referenced-by-count":5,"title":["Quantification of Fas protein in CSF of patients with neurocysticercosis"],"prefix":"10.1590","volume":"70","author":[{"given":"Jos\u00e9 Augusto","family":"Camargo","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Ferreira","family":"Bertolucci","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0001-706X(03)00064-0","article-title":"The control of human (neuro)cysticercosis: which way forward?","volume":"87","author":"Engels D","year":"2003","journal-title":"Acta Trop","ISSN":"http:\/\/id.crossref.org\/issn\/0001-706X","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1590\/S0037-86822001000300010","article-title":"Neurocisticercose","volume":"34","author":"Takayanagui OM","year":"2001","journal-title":"Rev Soc Bras Med Trop","ISSN":"http:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s004360050701","article-title":"Cellular immune responses in human neurocysticercosis","volume":"86","author":"Grewal JS","year":"2000","journal-title":"Parasitol Res","ISSN":"http:\/\/id.crossref.org\/issn\/0044-3255","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.57.2.177","article-title":"Proposed diagnostic criteria for neurocysticercosis","volume":"57","author":"Del Brutto OH","year":"2001","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.trstmh.2005.06.028","article-title":"Pleomorphism of the clinical manifestations of neurocysticercosis","volume":"100","author":"Patel R","year":"2006","journal-title":"Trans R Soc Trop Med Hyg","ISSN":"http:\/\/id.crossref.org\/issn\/0035-9203","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.parint.2005.11.016","article-title":"Clinical aspects of neurocysticercosis","volume":"55","author":"Takayanagui OM","year":"2006","journal-title":"Parasitol Int"},{"key":"ref7","first-page":"29:649","article-title":"Immunopathogenesis of neurocysticercosis: is damage mediated by the host immune response?","author":"Ostrosky-Zeichner L","year":"1999","journal-title":"Int J Parasitol","ISSN":"http:\/\/id.crossref.org\/issn\/0020-7519","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.med.51.1.187","article-title":"Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management","volume":"51","author":"White AC Jr","year":"2000","journal-title":"Ann Rev Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2003.08.008","article-title":"Neuron-specific enolase in patients with neurocysticercosis","volume":"217","author":"Lima JE","year":"2004","journal-title":"J Neurol Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0022-510X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1590\/S1516-44462006005000029","article-title":"Brain injury markers (S100B and NSE) in chronic cocaine dependents","volume":"29","author":"Kessler FHP","year":"2007","journal-title":"Rev Bras Psiquiatr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pneurobio.2006.12.002","article-title":"Apoptosis-inducing factor: a matter of neuron life and death","volume":"81","author":"Krantic S","year":"2007","journal-title":"Prog Neurobiol","ISSN":"http:\/\/id.crossref.org\/issn\/0301-0082","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.7533326","article-title":"The Fas death factor","volume":"267","author":"Nagata S","year":"1995","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref13","first-page":"131","article-title":"The biology of cell death in tumors","volume":"5","author":"Wyllie AH","year":"1985","journal-title":"Anticancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/0250-7005","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0317167100048757","article-title":"A proposal for classification of neurocysticercosis","volume":"21","author":"Carpio A","year":"1994","journal-title":"Can J Neurol Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0317-1671","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garc\u00eda HH","year":"2002","journal-title":"Clin Microbiol Rev","ISSN":"http:\/\/id.crossref.org\/issn\/0893-8512","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4274(99)00252-0","article-title":"Activation of apoptosis pathways by anticancer treatment","volume":"113","author":"Debatin KM","year":"2000","journal-title":"Toxicol Lett","ISSN":"http:\/\/id.crossref.org\/issn\/0378-4274","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner MO","year":"2000","journal-title":"Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0300-483X(03)00089-1","article-title":"Comparative cytotoxicity of dimethylamide-crotonin in the promyelocytic leukemia cell line (HL60) and human peripheral blood mononuclear cells","volume":"188","author":"Anazetti MC","year":"2003","journal-title":"Toxicology","ISSN":"http:\/\/id.crossref.org\/issn\/0300-483X","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1071-9164(03)00129-5","article-title":"Mitochondria play a critical role in cardioprotection","volume":"10","author":"Mar\u00edn-Garc\u00eda J","year":"2004","journal-title":"J Card Fail","ISSN":"http:\/\/id.crossref.org\/issn\/1071-9164","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0165-6147(03)00125-1","article-title":"Mitochondrion-mediated apoptosis in HIV-1 infection","volume":"24","author":"Badley AD","year":"2003","journal-title":"Trends Pharmacol Sci","ISSN":"http:\/\/id.crossref.org\/issn\/0165-6147","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(96)13257-2","article-title":"The soluble form of Fas molecule is elevated in parkinsonian brain tissues","volume":"220","author":"Mogi M","year":"1996","journal-title":"Neurosci Lett","ISSN":"http:\/\/id.crossref.org\/issn\/0304-3940","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0165-5728(97)00177-X","article-title":"Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients","volume":"82","author":"Ciusani E","year":"1998","journal-title":"J Neuroimmunol","ISSN":"http:\/\/id.crossref.org\/issn\/0165-5728","issn-type":"print"},{"key":"ref23","first-page":"39","article-title":"Detection of the soluble form of the Fas molecule in patients with multiple sclerosis","volume":"25","author":"Zhou WB","year":"2000","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0006-8993(00)02363-5","article-title":"Increased cerebrospinal fluid Fas (Apo-1) levels in Alzheimer's disease: Relationship with IL-6 concentrations","volume":"869","author":"Mart\u00ednez M","year":"2000","journal-title":"Brains Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/adc.84.4.369","article-title":"Increases cerebrospinal fluid concentrations of soluble Fas (CD95\/Apo-1) in hydrocephalus","volume":"84","author":"Felderhoff-Mueser U","year":"2001","journal-title":"Arch Dis Child","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1212\/01.WNL.0000110188.37546.51","article-title":"CSF soluble Fas correlates with the severity of HIV-associated dementia","volume":"62","author":"Towfighi A","year":"2004","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref27","first-page":"1108","article-title":"Soluble Fas and cancer","volume":"7","author":"Owen-Schaub L","year":"2001","journal-title":"Clin Cancer Res","ISSN":"http:\/\/id.crossref.org\/issn\/1078-0432","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1985.00360030074016","article-title":"Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases","volume":"145","author":"Sotelo J","year":"1985","journal-title":"Arch Intern Med","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref29","series-title":"Estudo dos amino\u00e1cidos neurotransmissores e da prote\u00edna Fas no l\u00edquor nas diferentes fases da neurocisticercose humana","author":"Camargo JA","year":"2010"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v70n4\/07.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T05:18:07Z","timestamp":1495862287000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2012000400007&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0004-282X2012000400007"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2012000400007","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}